Acne Vulgaris
Welcome,         Profile    Billing    Logout  
 29 Companies   28 Products   28 Products   27 Mechanisms of Action   0 Trials   447 News 


«12345678910»
  • ||||||||||  adapalene/benzoyl peroxide / Generic mfg.
    Phase classification, Adherence:  Effect of Samples on Acne Treatment With Epiduo (clinicaltrials.gov) -  Apr 19, 2017   
    P4,  N=20, Completed, 
    Phase classification: P=N/A --> P4
  • ||||||||||  tazarotene topical / Generic mfg.
    Enrollment closed:  A Study Comparing Tazarotene Cream 0.1% to TAZORAC (clinicaltrials.gov) -  Apr 5, 2017   
    P3,  N=1110, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  Efficacy Study in Patients With Acne Vulgaris. (clinicaltrials.gov) -  Mar 20, 2017   
    P2,  N=300, Active, not recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Mar 2017
  • ||||||||||  tazarotene topical / Generic mfg.
    Trial primary completion date:  A Study Comparing Tazarotene Cream 0.1% to TAZORAC (clinicaltrials.gov) -  Mar 20, 2017   
    P3,  N=1110, Recruiting, 
    Trial primary completion date: Dec 2016 --> Mar 2017 Trial primary completion date: Mar 2017 --> Aug 2017
  • ||||||||||  finasteride / Generic mfg.
    Trial primary completion date:  Finasteride Treatment of Severe Nodulocystic Acne (clinicaltrials.gov) -  Feb 7, 2017   
    P2,  N=180, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Jul 2017
  • ||||||||||  DMT210 / Dermata Therap
    Enrollment open:  DMT210 Topical Gel in the Treatment of Acne Rosacea (clinicaltrials.gov) -  Jan 24, 2017   
    P2,  N=104, Recruiting, 
    Trial primary completion date: Dec 2016 --> Mar 2017 Not yet recruiting --> Recruiting
  • ||||||||||  clindamycin phosphate / Generic mfg., tazarotene topical / Generic mfg., adapalene / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris (clinicaltrials.gov) -  Jan 18, 2017   
    P4,  N=60, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | N=100 --> 60 | Trial primary completion date: Sep 2016 --> Dec 2016 | Recruiting --> Completed
  • ||||||||||  berdazimer sodium (SB204) / Sato Pharma, Novan
    Clinical:  Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris (clinicaltrials.gov) -  Jan 4, 2017   
    P1,  N=18, Active, not recruiting, 
    Recruiting --> Completed | N=100 --> 60 | Trial primary completion date: Sep 2016 --> Dec 2016 | Recruiting --> Completed Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  minocycline (BPX-01) / Timber Pharma
    Enrollment closed:  BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Jan 4, 2017   
    P2,  N=225, Active, not recruiting, 
    Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Active, not recruiting
  • ||||||||||  adapalene / Generic mfg.
    Enrollment closed, Trial primary completion date:  A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments (clinicaltrials.gov) -  Dec 23, 2016   
    P4,  N=130, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Apr 2017
  • ||||||||||  berdazimer sodium (SB204) / Sato Pharma, Novan
    Clinical:  P3 Study in Acne Comparing Once Daily SB204 and Vehicle (clinicaltrials.gov) -  Dec 22, 2016   
    P3,  N=1306, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Apr 2017 Recruiting --> Active, not recruiting
  • ||||||||||  tazarotene topical / Generic mfg.
    Enrollment open:  A Study Comparing Tazarotene Cream 0.1% to TAZORAC (clinicaltrials.gov) -  Oct 30, 2016   
    P3,  N=1110, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
  • ||||||||||  XEN-801 / Xenon
    Trial primary completion date:  A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel (clinicaltrials.gov) -  Sep 1, 2016   
    P1/2,  N=198, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Aug 2016 Trial primary completion date: Oct 2016 --> Mar 2017
  • ||||||||||  Seysara (sarecycline) / Paratek, Almirall
    Trial primary completion date:  Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne (clinicaltrials.gov) -  Aug 30, 2016   
    P3,  N=1000, Recruiting, 
    Trial primary completion date: Jul 2016 --> Jan 2017 Trial primary completion date: Jul 2016 --> Jan 2017